18 results
IDSA Recommendations for the Treatment of Clostridium difficile Infection in Adults
Source: https://doi.org/10.1093/cid/cix1085

#Management #Clostridium #CDifficile #IDSA2017 #Guidelines
IDSA Recommendations ... for the Treatment ... cid/cix1085 #Management ... #IDSA2017 #Guidelines ... #Adults #taper
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ... #Management # ... Clostridium #CDifficile ... #IDSA2017 #Guidelines
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... #Clostridium #CDifficile
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Guidelines - ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
IDSA 2017 CDiff Guidelines - Table 2. Recommendations for the Treatment of Clostridium difficile Infection in Children

#Management
IDSA 2017 CDiff ... Guidelines - Table ... in Children #Management ... #Clostridium #CDifficile ... #IDSA2017 #Guidelines
Asymptomatic Bacteriuria - IDSA Indications for Treatment
Healthy non-pregnant women - NO
Healthy pregnant women - YES
Functionally impaired
Indications for ... impaired older adults ... www.idsociety.org/practice-guideline ... #Indications #Treatment ... #management #UTI
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... for the Management ... with ‘treatment ... clinical practice guideline1 ... #Pharmacology #
Guidelines on Management of Clostridioides difficile Infection (CDI) in Adults
 • Non-Severe CDI
 • Severe CDI
Guidelines on Management ... Infection (CDI) in Adults ... #CDiff #CDI #management ... #pharmacology # ... treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... : 250 mcg tablet ... 2019 COPD GOLD guidelines ... exacerbations. 2019 GOLD guidelines ... #Pharmacology #
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy